Latest papers

Comparison of reduced intensity and myeloablative conditioning regimens for stem cell transplantation in patients with malignancies: a meta-analysis.

Cytomegalovirus infection in non-transplant patients with hematologic neoplasms: a case series.

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.

Physical activity and hematologic cancer prevention.

Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.

PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasms.

[Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer].

Influenza vaccination in patients with cancer: an overview.

Steroid receptor and microRNA regulation in cancer.

Recent advances of IMiDs in cancer therapy.

Beyond hairy cell: the activity of cladribine in other hematologic malignancies.

Blood transfusions and the subsequent risk of hematologic malignancies.

Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.

Acute myeloid leukemia diagnosis in the 21st century.

Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study.

Heritability of hematologic malignancies: from pedigrees to genomics.

Targeting autophagy to fight hematopoietic malignancies.

Th17/Treg ratio in human graft-versus-host disease.

Cutaneous CD4+ CD56+ hematologic malignancies.

FDG PET/CT Manifestations of Hematopoietic Malignancies of the Breast